J&J, free from rival bidders, made Momenta wait on $6.5B deal
Johnson & Johnson’s $6.5 billion takeover of Momenta Pharmaceuticals came out of the blue last […]
Johnson & Johnson’s $6.5 billion takeover of Momenta Pharmaceuticals came out of the blue last […]
Under intense criticism for his statement that convalescent plasma donated by former coronavirus patients […]
Drugmaker Johnson & Johnson plans to spend a hefty sum to acquire a company focused […]
Shares of CureVac (NSDQ:CVAC) continue to rise after the company reportedly raised $213.3 million in […]
The buzzy life sciences company Verily is looking to speed up COVID testing with a […]
Blood diagnostic testing developer Sight Diagnostics announced this week that it raised $71 million in a Series […]
As we cross the mid-point of 2020, the second quarter turned out to be the […]
Drug- and medtech developer Windtree Therapeutics (NSDQ:WINT) today announced it named John Hamill as SVP and chief […]
Dive Brief: The Biomedical Advanced Research and Development Authority has teamed with Northwestern University spinout […]
Bigfoot Biomedical has brought on Dr. Jim Malone — a 21-year clinical research veteran at […]
SARASOTA, Fla., May 22, 2020 /PRNewswire/ — INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating […]
VALENCIA, Calif., May 06, 2020 (GLOBE NEWSWIRE) — SetPoint Medical, a clinical-stage bioelectronic medicine company […]
Dive Brief: FDA has granted its first two emergency use authorizations for extracorporeal blood purification […]
The COVID-19 pandemic may be disrupting clinical trials and drug launches, but it’s not holding […]
Cerus Corporation (Nasdaq: CERS) announced today that it has formed a collaborative research group with […]
Cleveland-based XaTek Inc. announced receiving FDA Breakthrough Device designation for ClotChip, a handheld device that […]
A new handheld 3D printer that looks sort of like a packing tape dispenser can […]
3D printing of artificial scaffolds intended to replace injured tissues has become a ballyhooed technology […]
INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared […]
Researchers at the Laboratory of Bionanophotonic Systems (BIOS) at EPFL’s School of Engineering have developed […]
Transdermal drug therapy developer Dyve Biosciences announced that it appointed longtime Pfizer executive Chuck Harbert to the […]
Sanofi (NYSE:SNY) announced today that it is planning to tender an offer to acquire all outstanding […]
Seventh Sense Biosystems, a company based outside of Boston, MA, won FDA clearance for its […]
Trapping adenosine at the site of a bone break speeds recovery in mice DURHAM, N.C. […]
New Five-Year Agreement Maintains Exclusive Use of INTERCEPT Platelets and Expands Use of INTERCEPT Plasma […]
Haemonetics (NYSE:HAE) said this week it opened its new global headquarters in Boston. The new location […]
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a […]
The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among […]
GE Healthcare (NYSE:GE) and Fujifilm (TSE:4901) are entering into a partnership with Harvard University and Massachusetts Institute of Technology to establish a […]
Electrospinning is a maturing manufacturing technology that is already being used in medicine to produce […]
The multi-center, single-arm, open-label study recorded an overall medication adherence rate of 93% alongside strong […]
Owlstone Medical last week announced that it has forged a partnership with Thermo Fisher Scientific‘s […]
Researchers at the University of Wisconsin-Madison have developed an injectable flexible electrode that can aid […]
Eyevensys, a clinical-stage biotechnology company based in France, has developed a method to perform non-viral […]
Following its mammoth $411 million IPO in September, 10x Genomics delivered its first earnings report […]
Treatments for high cholesterol stemming from a rare genetic disorder focus on lowering patients’ LDL, […]
Stem cells hold a great deal of promise in treating a huge variety of human […]
Dexcom (NSDQ:DXCM) shares jumped after hours today on third-quarter results that bettered the consensus forecast. […]
Boston Scientific announced positive data Tuesday for two paclitaxel devices during separate late-breaking clinical trial presentations […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.